Voriconazole metabolism is associated with the number of skin cancers per patient
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03135-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Jacqueline I Ike und 10 weiteren Autor:innen. Beteiligte Einrichtung: Meharry Medical College, Nashville, TN, USA. Hauptthemen laut MEDLINE: Voriconazole, Skin Neoplasms, Antifungal Agents, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, NCATS NIH HHS, Skin Cancer Foundation.
Abstract (Originalsprache)
Voriconazole exposure is associated with skin cancer, but it is unknown how the full spectrum of its metabolizer phenotypes impacts this association. We conducted a retrospective cohort study to determine how variation in metabolism of voriconazole as measured by metabolizer status of CYP2C19 is associated with the total number of skin cancers a patient develops and the rate of development of the first skin cancer after treatment. There were 1,739 organ transplant recipients with data on CYP2C19 phenotype. Of these, 134 were exposed to voriconazole. There was a significant difference in the number of skin cancers after transplant based on exposure to voriconazole, metabolizer phenotype, and the interaction of these two ( p < 0.01 for all three). This increase was driven primarily by number of squamous cell carcinomas among rapid metabolizes with voriconazole exposure ( p < 0.01 for both). Patients exposed to voriconazole developed skin cancers more rapidly than those without exposure (Fine-Grey hazard ratio 1.78, 95% confidence interval 1.19–2.66). This association was similarly driven by development of SCC (Fine-Grey hazard ratio 1.83, 95% confidence interval 1.14–2.94). Differences in voriconazoles metabolism are associated with an increase in the number of skin cancers developed after transplant, particularly SCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meharry Medical College, Nashville, TN, USA.
- Vanderbilt University College of Arts and Sciences, Nashville, TN, USA.
- Vanderbilt University School of Medicine, Nashville, TN, USA.
- State University of New York Downstate College of Medicine, Brooklyn, NY, USA.
- Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
- Irvine Department of Dermatology, University of California, Davis, USA.
Förderung
- CSRD VA
- NCATS NIH HHS
- Skin Cancer Foundation
Zitieren
APA
Ike, J. I., Smith, I. T., Mosley, D., Madden, C., Grossarth, S., Halle, B. R., Lewis, A., Mentch, F., Hakonarson, H., Bastarache, L., & Wheless, L. (2024). Voriconazole metabolism is associated with the number of skin cancers per patient. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03135-5
Vancouver
Ike JI, Smith IT, Mosley D, Madden C, Grossarth S, Halle BR, et al. Voriconazole metabolism is associated with the number of skin cancers per patient. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03135-5
BibTeX
@article{Ike2024,
author = {Ike, Jacqueline I and Smith, Isabelle T and Mosley, Dominique and Madden, Christopher and Grossarth, Sarah and Halle, Briana R and Lewis, Adam and Mentch, Frank and Hakonarson, Hakon and Bastarache, Lisa and Wheless, Lee},
title = {Voriconazole metabolism is associated with the number of skin cancers per patient},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03135-5}
}
EUVIMED